logo

BOLT

Bolt Biotherapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

BOLT Profile

Bolt Biotherapeutics, Inc.

A clinical-stage biopharmaceutical company that develops novel immuno-oncology therapeutics for the treatment of cancer

Pharmaceutical
01/22/2015
02/05/2021
NASDAQ Stock Exchange
52
12-31
Common stock
900 Chesapeake Drive, Redwood City, California 94063
--
Bolt Biotherapeutics, Inc., incorporated in Delaware on January 22, 2015 as Bolt Therapeutics, Inc., is headquartered in Redwood City, California. The company changed its name to Bolt Biotherapeutics, Inc., on July 29, 2015. The company is a clinical-stage immuno-oncology company that develops tumor-targeted therapies utilizing the innate and adaptive immune systems.